Cargando…

Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine

BACKGROUND: Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. CASE REPORT: We report a case of atypical presentation of EN mim...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzoabi, Nasser, Alqahtani, Jamal, Algamdi, Bader, Almutairi, Mohammed, Alratroot, Jumana, Alkhaldi, Saud, Alqahtani, Shatha, Alakloby, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978813/
https://www.ncbi.nlm.nih.gov/pubmed/35422564
http://dx.doi.org/10.5455/medarh.2022.76.72-74
_version_ 1784681036581437440
author Alzoabi, Nasser
Alqahtani, Jamal
Algamdi, Bader
Almutairi, Mohammed
Alratroot, Jumana
Alkhaldi, Saud
Alqahtani, Shatha
Alakloby, Omar
author_facet Alzoabi, Nasser
Alqahtani, Jamal
Algamdi, Bader
Almutairi, Mohammed
Alratroot, Jumana
Alkhaldi, Saud
Alqahtani, Shatha
Alakloby, Omar
author_sort Alzoabi, Nasser
collection PubMed
description BACKGROUND: Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. CASE REPORT: We report a case of atypical presentation of EN mimicking cellulitis in a patient who received the first dose of the Pfizer-BioNTech COVID-19 vaccine. A 38-year-old healthy woman who developed painful swelling on the left leg one week after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Skin biopsy was revealed septal panniculitis. Due to the temporal association and the absence of other identifiable causes, Pfizer-BioNTech COVID-19 vaccine-related EN would be the most likely explanation. CONCLUSION: COVID-19 vaccines could be associated with rare side effects that should be reported for a better understanding of related outcomes of COVID-19 vaccination. This case was reported to keep in mind that EN can have atypical presentation as a rare side effect of COVID-19 vaccines.
format Online
Article
Text
id pubmed-8978813
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Academy of Medical Sciences of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-89788132022-04-13 Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine Alzoabi, Nasser Alqahtani, Jamal Algamdi, Bader Almutairi, Mohammed Alratroot, Jumana Alkhaldi, Saud Alqahtani, Shatha Alakloby, Omar Med Arch Case Report BACKGROUND: Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. CASE REPORT: We report a case of atypical presentation of EN mimicking cellulitis in a patient who received the first dose of the Pfizer-BioNTech COVID-19 vaccine. A 38-year-old healthy woman who developed painful swelling on the left leg one week after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Skin biopsy was revealed septal panniculitis. Due to the temporal association and the absence of other identifiable causes, Pfizer-BioNTech COVID-19 vaccine-related EN would be the most likely explanation. CONCLUSION: COVID-19 vaccines could be associated with rare side effects that should be reported for a better understanding of related outcomes of COVID-19 vaccination. This case was reported to keep in mind that EN can have atypical presentation as a rare side effect of COVID-19 vaccines. Academy of Medical Sciences of Bosnia and Herzegovina 2022-02 /pmc/articles/PMC8978813/ /pubmed/35422564 http://dx.doi.org/10.5455/medarh.2022.76.72-74 Text en © 2022 Nasser Alzoabi, Jamal Alqahtani, Bader Algamdi, Mohammed Almutairi, Jumana Alratroot, Saud Alkhaldi, Shatha Alqahtani, Omar Alakloby https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Alzoabi, Nasser
Alqahtani, Jamal
Algamdi, Bader
Almutairi, Mohammed
Alratroot, Jumana
Alkhaldi, Saud
Alqahtani, Shatha
Alakloby, Omar
Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title_full Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title_fullStr Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title_full_unstemmed Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title_short Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine
title_sort atypical presentation of erythema nodosum following pfizer-biontech covid-19 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978813/
https://www.ncbi.nlm.nih.gov/pubmed/35422564
http://dx.doi.org/10.5455/medarh.2022.76.72-74
work_keys_str_mv AT alzoabinasser atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT alqahtanijamal atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT algamdibader atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT almutairimohammed atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT alratrootjumana atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT alkhaldisaud atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT alqahtanishatha atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine
AT alaklobyomar atypicalpresentationoferythemanodosumfollowingpfizerbiontechcovid19vaccine